Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities:
Consolidated net income (loss)	$ 2,561	$ (14,462)
Adjustments to reconcile consolidated net income (loss) to net cash provided by operating activities:
Depreciation and amortization	5,189	4,614
Stock-based compensation expense	4,349	3,780
Provision for doubtful accounts	7	0
Litigation-contingency expense	0	17,200
Decrease in long-term deferred revenue	0	(360)
Decrease (increase) in other assets	480	(99)
Deferred income taxes	(2)	4
Decrease in long-term income taxes payable	74	8
Change in current assets and liabilities, net	7,470	(8,103)
Net cash provided by operating activities	20,128	2,582
Investing activities:
Additions to property, plant and equipment and internal-use software	(4,550)	(7,270)
Net cash used for investing activities	(4,550)	(7,270)
Financing activities:
Proceeds from employee stock plans	3,166	1,756
Net cash provided by financing activities	3,166	1,756
Effect of foreign exchange rates on cash	82	(115)
Net increase (decrease) in cash and cash equivalents	18,826	(3,047)
Cash and cash equivalents at beginning of period	277,273	242,219
Cash and cash equivalents at end of period	296,099	239,172
Supplemental disclosure:
Purchases of property, plant and equipment and internal-use software incurred but not yet paid	$ 2,990	$ 1,983